Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 113, Issue 2, Pages 189-199
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/bju.12469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer
- (2013) Timothy J. Daskivich et al. ANNALS OF INTERNAL MEDICINE
- Impact of surgical margin status on prostate-cancer-specific mortality
- (2012) Heather J. Chalfin et al. BJU INTERNATIONAL
- Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
- (2012) Phillip M. Pierorazio et al. BJU INTERNATIONAL
- The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
- (2012) Xavier Durand et al. BJU INTERNATIONAL
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- ESUR prostate MR guidelines 2012
- (2012) Jelle O. Barentsz et al. EUROPEAN RADIOLOGY
- Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial
- (2012) Andrew Vickers et al. EUROPEAN UROLOGY
- High-Risk Prostate Cancer: From Definition to Contemporary Management
- (2012) Patrick J. Bastian et al. EUROPEAN UROLOGY
- Temporal Trends in Cause of Death Among Swedish and US Men with Prostate Cancer
- (2012) M. M. Epstein et al. JNCI-Journal of the National Cancer Institute
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram
- (2012) A Kutikov et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study
- (2012) Jean-Baptiste Beauval et al. UROLOGY
- Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy
- (2012) Matthias C. Roethke et al. WORLD JOURNAL OF UROLOGY
- Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level
- (2012) Gianluigi Taverna et al. Journal of Oncology
- Endorectal MRI of Prostate Cancer: Incremental Prognostic Importance of Gross Locally Advanced Disease
- (2011) Valdair F. Muglia et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Prostate cancer in Spain: from guidelines to clinical practice
- (2011) Antonio Alcaraz et al. BJU INTERNATIONAL
- The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance
- (2011) Hein van Poppel et al. BJU INTERNATIONAL
- Comorbidity and competing risks for mortality in men with prostate cancer
- (2011) Timothy J. Daskivich et al. CANCER
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- Consensus Criteria for the Use of Magnetic Resonance Imaging in the Diagnosis and Staging of Prostate Cancer: Not Ready for Routine Use
- (2011) Axel Heidenreich EUROPEAN UROLOGY
- Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort
- (2011) Thomas Hambrock et al. EUROPEAN UROLOGY
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- Older Age Predicts Decreased Metastasis and Prostate Cancer-Specific Death for Men Treated With Radiation Therapy: Meta-Analysis of Radiation Therapy Oncology Group Trials
- (2011) Daniel A. Hamstra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?
- (2011) Jiayi Huang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Percentage of Cancer Volume in Biopsy Cores Is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated With Dose-Escalated External Beam Radiotherapy
- (2011) Sean M. Vance et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Redefining High-Risk Prostate Cancer Based on Distant Metastases and Mortality After High-Dose Radiotherapy With Androgen Deprivation Therapy
- (2011) Rahul D. Tendulkar et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer
- (2011) Derya Yakar et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Gleason Score 7 Prostate Cancer on Needle Biopsy: Relation of Primary Pattern 3 or 4 to Pathological Stage and Progression After Radical Prostatectomy
- (2011) Ali Amin et al. JOURNAL OF UROLOGY
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
- (2011) Padraig Warde et al. LANCET
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
- (2011) A Marije Hoogland et al. MODERN PATHOLOGY
- Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification
- (2011) Guillaume Ploussard et al. UROLOGY
- Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination
- (2011) Evanguelos Xylinas et al. WORLD JOURNAL OF UROLOGY
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) A. Horwich et al. ANNALS OF ONCOLOGY
- Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging
- (2010) Nicolas Barry Delongchamps et al. BJU INTERNATIONAL
- Predictive models in external beam radiotherapy for clinically localized prostate cancer
- (2010) Mack Roach et al. CANCER
- Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
- (2010) Martin Spahn et al. EUROPEAN UROLOGY
- Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature
- (2010) Giovanni Lughezzani et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
- (2010) Louise Dickinson et al. EUROPEAN UROLOGY
- Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival
- (2010) Seth K. Bechis et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment strategies for high-risk locally advanced prostate cancer
- (2010) Seth A. Rosenthal et al. Nature Reviews Urology
- Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial
- (2010) Michel Bolla et al. RADIOTHERAPY AND ONCOLOGY
- Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation
- (2010) Martin Spahn et al. UROLOGIA INTERNATIONALIS
- Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
- (2009) Paul L. Nguyen et al. CANCER
- Gleason Pattern 5 Prostate Cancer: Further Stratification of Patients With High-Risk Disease and Implications for Future Randomized Trials
- (2009) Akash Nanda et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
- (2009) Andrew J. Stephenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
- (2009) Thomas Wiegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
- (2009) Matthew R. Cooperberg et al. JNCI-Journal of the National Cancer Institute
- Predictors of Positive Surgical Margins After Laparoscopic Robot Assisted Radical Prostatectomy
- (2009) Vincenzo Ficarra et al. JOURNAL OF UROLOGY
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
- (2009) Ian M. Thompson et al. JOURNAL OF UROLOGY
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?
- (2009) Stacy Loeb et al. UROLOGY
- Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial
- (2008) Nicholas D. James et al. BJU INTERNATIONAL
- Predicting Prostate Cancer Mortality Among Men With Intermediate to High-Risk Disease and Multiple Unfavorable Risk Factors
- (2008) Paul L. Nguyen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
- (2008) Seth A. Rosenthal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
- (2008) A. Bill-Axelson et al. JNCI-Journal of the National Cancer Institute
- Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
- (2008) Anders Widmark et al. LANCET
- Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results
- (2008) Martijn P.M.Q. van Gils et al. PROSTATE
- Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials
- (2007) Laurence Collette EUROPEAN UROLOGY
- Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy
- (2007) Ofer Yossepowitch et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started